Published in Gene Therapy Weekly, October 26th, 2006
Study 1: According to recent research from the United States, specific targeting of pancreatic islet cells is achieved in vivo by insulin-promoter-driven adenoviral conjugated reporter genes.
"The objective of this study was to determine whether rat insulin promoter (RIP) could, in a mouse model, direct expression of an adenovirus-mediated reporter gene specifically into pancreatic islets via systemic delivery," wrote X.P. Wang and colleagues, Baylor College of Medicine.
"Five hundred and eight base pairs of the RIP DNA sequence were constructed into...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-10-26)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.